Search Results - "Culp PA"

Tiny tools closing the gap: nanobodies in research and therapy.

Authors: Abdellatif, Mustafa Rajurkar, Jyotirmoy Leonhardt, Heinrich

Source: Function. Apr2026, Vol. 7 Issue 2, p1-20. 20p.

Multiomics profiling of zebrafish embryonic cell line PAC2 across growth phases to assess its relevance for toxicological studies.

Authors: Degeratu, Mihai-Ovidiu Bertoli, Jessica Huwa, Nikolai et al.

Source: PLoS ONE. 4/17/2026, Vol. 21 Issue 4, p1-36. 36p.

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.

Authors: Bagheri A Culp PA DuBridge RB et al.

Source: Biochemistry and biophysics reports [Biochem Biophys Rep] 2022 Jan 12; Vol. 29, pp. 101205. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE

Nanobodies and their derivatives: pioneering the future of cancer immunotherapy.

Authors: Li, Haixia Zhou, Quan Cao, Nan et al.

Source: Cell Communication & Signaling. 6/6/2025, Vol. 23 Issue 1, p1-25. 25p.

Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.

Authors: Ding, Ziqiang Sun, Shuyang Wang, Xuan et al.

Source: Journal of Hematology & Oncology. 11/29/2023, Vol. 16 Issue 1, p1-20. 20p.

Trispecific antibodies for cancer immunotherapy.

Authors: Yao, Yin Hu, Yiyin Wang, Fei

Source: Immunology. Aug2023, Vol. 169 Issue 4, p389-399. 11p.

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer.

Authors: Rudin, Charles M. Reck, Martin Johnson, Melissa L. et al.

Source: Journal of Hematology & Oncology. 6/24/2023, Vol. 16 Issue 1, p1-21. 21p.

Pharmacology of manipulating lean body mass.

Authors: Sepulveda, Patricio V Bush, Ernest D Baar, Keith

Source: Clinical & Experimental Pharmacology & Physiology. Jan2015, Vol. 42 Issue 1, p1-13.

T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives.

Authors: Muthughavi K Khokhar M Jha HC et al.

Source: Frontiers in immunology [Front Immunol] 2026 Jun 03; Vol. 17, pp. 1755512. Date of Electronic Publication: 2026 Jun 03 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Identification of a new risk score model based on hypoxia and EMT-related genes for predicting lung squamous cell carcinoma prognosis.

Authors: Zhuang X Yu S Yang S et al.

Source: Medicine [Medicine (Baltimore)] 2023 Nov 03; Vol. 102 (44), pp. e35572.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

TWEAK enhances TGF-β-induced epithelialmesenchymal transition in human bronchial epithelial cells.

Authors: Yukinari Itoigawa Norihiro Harada Sonoko Harada et al.

Source: Respiratory Research. 2015, Vol. 16 Issue 1, p1-15. 15p. 1 Color Photograph, 2 Charts, 8 Graphs.

Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts.

Authors: de Plater, Ludmilla Vincent-Salomon, Anne Berger, Frédérique et al.

Source: PLoS ONE. Nov2014, Vol. 9 Issue 11, p1-11. 11p.

Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells.

Authors: Sanz, Ana Belen Sanchez-Niño, Maria Dolores Carrasco, Susana et al.

Source: PLoS ONE. Oct2012, Vol. 7 Issue 10, Special section p1-15. 15p.

Revolutionizing cancer immunotherapy: T cell engagers beyond hematologic malignancies toward solid tumors.

Authors: Wu X Li P Li T et al.

Source: Frontiers in immunology [Front Immunol] 2026 May 20; Vol. 17, pp. 1774471. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Immune cell engagers in lung cancer.

Authors: Kang J Zhang M He Y et al.

Source: Frontiers in immunology [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1746093. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

TWEAK-Fn14: a promising target for cardio-cerebrovascular diseases and brain-heart syndrome.

Authors: Fei Q Chang J Jiang T et al.

Source: Frontiers in immunology [Front Immunol] 2026 Apr 01; Vol. 16, pp. 1710055. Date of Electronic Publication: 2026 Apr 01 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Current landscape of T-cell engagers in early-phase clinical development in solid cancers.

Authors: Spinazzola A Iannantuono GM Gulley JL et al.

Source: Frontiers in immunology [Front Immunol] 2025 Oct 06; Vol. 16, pp. 1665838. Date of Electronic Publication: 2025 Oct 06 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

CONTROL OF TRANSLATION INITIATION IN ANIMALS.

Authors: Gray, Nicola K. Wickens, Marvin

Source: Annual Review of Cell & Developmental Biology. 1998, Vol. 14 Issue 1, p399. 60p.

Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation.

Authors: Kristof A Karunakaran K Allen C et al.

Source: Genome biology [Genome Biol] 2025 Jun 12; Vol. 26 (1), pp. 164. Date of Electronic Publication: 2025 Jun 12.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Engaging T cells for cleanup.

Authors: Mungalov RV Mushenkova NV Chudakov DM et al.

Source: Frontiers in immunology [Front Immunol] 2025 May 06; Vol. 16, pp. 1551424. Date of Electronic Publication: 2025 May 06 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE